ID

30607

Description

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00930475

Lien

https://clinicaltrials.gov/show/NCT00930475

Mots-clés

  1. 17/06/2018 17/06/2018 -
Détendeur de droits

see clinicaltrials.gov

Téléchargé le

17 juin 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00930475

Eligibility Breast Cancer NCT00930475

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult female patients
Description

Gender; Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
at least two prior chemotherapies due to metastatic or inoperable breast cancer
Description

Prior Chemotherapy Due to Carcinoma breast stage IV; Prior Chemotherapy Due to Breast Carcinoma, Inoperable

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0278488
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0678222
UMLS CUI [2,4]
C0205187
karnofsky performance status of at least 60%
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
pretreatment with at least one taxane and one anthracycline
Description

Pretreatment taxane; Pretreatment Anthracyclines

Type de données

boolean

Alias
UMLS CUI [1,1]
C3539076
UMLS CUI [1,2]
C0215136
UMLS CUI [2,1]
C3539076
UMLS CUI [2,2]
C0282564
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with mtor-inhibitors, carboplatin, cisplatin or oxaliplatin
Description

mTOR Inhibitor, Therapeutic procedure, Previous; Carboplatin, Therapeutic procedure, Previous; Cisplatin, Therapeutic procedure, Previous; oxaliplatin, Therapeutic procedure, Previous

Type de données

boolean

Alias
UMLS CUI [1,1]
C2746052
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C0079083
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0205156
UMLS CUI [3,1]
C0008838
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0205156
UMLS CUI [4,1]
C0069717
UMLS CUI [4,2]
C0087111
UMLS CUI [4,3]
C0205156
inadequate organ function including bone marrow function
Description

body system or organ function, Inadequate

Type de données

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205412
bleeding tumours
Description

Malignant Neoplasms, Hemorrhage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0019080
known uncontrolled metastases in cns or carcinomatous meningosis
Description

CNS metastases, Uncontrolled; Meningeal Carcinomatosis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0220654
patients who have been treated during the last five days with inhibitors or inducers of cyp3a
Description

Cytochrome P450 3A4 Inhibitor, Therapeutic procedure, Previous; Cytochrome P450 3A4 Inducer, Therapeutic procedure, Previous

Type de données

boolean

Alias
UMLS CUI [1,1]
C3830624
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C3830625
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0205156
serious pulmonary, neurological, endocrinological or other disorders interfering with this study medication, especially patients with known lung fibrosis, emphysema or severe copd
Description

Bronchopulmonary disease, Serious, Interferes with clinical trial drug; nervous system disorder, Serious, Interferes with, clinical trial drug; Endocrine System Diseases, Serious, Interferes with clinical trial drug; Disease, Other, Interferes with clinical trial drug

Type de données

boolean

Alias
UMLS CUI [1,1]
C1096000
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C3854006
UMLS CUI [2,1]
C0027765
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C3854006
UMLS CUI [3,1]
C0014130
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0521102
UMLS CUI [3,4]
C3854006
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0521102
UMLS CUI [4,4]
C3854006

Similar models

Eligibility Breast Cancer NCT00930475

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender; Age
Item
adult female patients
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Prior Chemotherapy Due to Carcinoma breast stage IV; Prior Chemotherapy Due to Breast Carcinoma, Inoperable
Item
at least two prior chemotherapies due to metastatic or inoperable breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,3])
C1514457 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
Karnofsky Performance Status
Item
karnofsky performance status of at least 60%
boolean
C0206065 (UMLS CUI [1])
Pretreatment taxane; Pretreatment Anthracyclines
Item
pretreatment with at least one taxane and one anthracycline
boolean
C3539076 (UMLS CUI [1,1])
C0215136 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C0282564 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
mTOR Inhibitor, Therapeutic procedure, Previous; Carboplatin, Therapeutic procedure, Previous; Cisplatin, Therapeutic procedure, Previous; oxaliplatin, Therapeutic procedure, Previous
Item
previous treatment with mtor-inhibitors, carboplatin, cisplatin or oxaliplatin
boolean
C2746052 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0079083 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C0008838 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
C0069717 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
body system or organ function, Inadequate
Item
inadequate organ function including bone marrow function
boolean
C0678852 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
Malignant Neoplasms, Hemorrhage
Item
bleeding tumours
boolean
C0006826 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
CNS metastases, Uncontrolled; Meningeal Carcinomatosis
Item
known uncontrolled metastases in cns or carcinomatous meningosis
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0220654 (UMLS CUI [2])
Cytochrome P450 3A4 Inhibitor, Therapeutic procedure, Previous; Cytochrome P450 3A4 Inducer, Therapeutic procedure, Previous
Item
patients who have been treated during the last five days with inhibitors or inducers of cyp3a
boolean
C3830624 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C3830625 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Bronchopulmonary disease, Serious, Interferes with clinical trial drug; nervous system disorder, Serious, Interferes with, clinical trial drug; Endocrine System Diseases, Serious, Interferes with clinical trial drug; Disease, Other, Interferes with clinical trial drug
Item
serious pulmonary, neurological, endocrinological or other disorders interfering with this study medication, especially patients with known lung fibrosis, emphysema or severe copd
boolean
C1096000 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C3854006 (UMLS CUI [1,4])
C0027765 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C3854006 (UMLS CUI [2,4])
C0014130 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C3854006 (UMLS CUI [3,4])
C0012634 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0521102 (UMLS CUI [4,3])
C3854006 (UMLS CUI [4,4])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial